- Company Overview for OXFORD DRUG DESIGN LIMITED (04305857)
- Filing history for OXFORD DRUG DESIGN LIMITED (04305857)
- People for OXFORD DRUG DESIGN LIMITED (04305857)
- Registers for OXFORD DRUG DESIGN LIMITED (04305857)
- More for OXFORD DRUG DESIGN LIMITED (04305857)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
29 Oct 2024 | CS01 | Confirmation statement made on 29 October 2024 with updates | |
11 Oct 2024 | AP01 | Appointment of Dr Boris Ayzikovich as a director on 17 September 2024 | |
03 May 2024 | AA | Total exemption full accounts made up to 31 December 2023 | |
06 Nov 2023 | CS01 | Confirmation statement made on 29 October 2023 with updates | |
18 Oct 2023 | TM01 | Termination of appointment of David Ian Ford as a director on 3 October 2023 | |
27 Sep 2023 | AA | Total exemption full accounts made up to 31 December 2022 | |
19 Jun 2023 | CH01 | Director's details changed for Mr Paul William Finn on 21 July 2022 | |
19 Apr 2023 | AP03 | Appointment of Ms Sarah Jane Hargreaves as a secretary on 17 April 2023 | |
19 Apr 2023 | TM02 | Termination of appointment of Nikki Marie Cooper as a secretary on 17 April 2023 | |
19 Apr 2023 | TM01 | Termination of appointment of Ip2Ipo Services Limited as a director on 17 April 2023 | |
12 Nov 2022 | CS01 | Confirmation statement made on 29 October 2022 with updates | |
07 Sep 2022 | AA | Total exemption full accounts made up to 31 December 2021 | |
03 Aug 2022 | AP02 | Appointment of Ip2Ipo Services Limited as a director on 26 July 2022 | |
03 Aug 2022 | TM01 | Termination of appointment of Oliver Robert Lyth as a director on 26 July 2022 | |
26 Jul 2022 | AP01 | Appointment of Mr Oliver Robert Lyth as a director on 26 July 2022 | |
16 Jun 2022 | MA | Memorandum and Articles of Association | |
16 Jun 2022 | RESOLUTIONS |
Resolutions
|
|
14 Jun 2022 | SH01 |
Statement of capital following an allotment of shares on 13 June 2022
|
|
04 Apr 2022 | SH01 |
Statement of capital following an allotment of shares on 31 March 2022
|
|
23 Feb 2022 | AD01 | Registered office address changed from The Walbrook Building 25 Walbrook London EC4N 8AF England to Oxford Centre for Innovation New Road Oxford OX1 1BY on 23 February 2022 | |
31 Jan 2022 | SH01 |
Statement of capital following an allotment of shares on 24 January 2022
|
|
04 Jan 2022 | RESOLUTIONS |
Resolutions
|
|
17 Nov 2021 | PSC08 | Notification of a person with significant control statement | |
09 Nov 2021 | PSC07 | Cessation of Ip2Ipo Limited as a person with significant control on 29 July 2019 | |
09 Nov 2021 | CS01 | Confirmation statement made on 29 October 2021 with updates |